
Leila Jaafar, Nuclidium CEO
Swiss and German radiopharma biotech Nuclidium collects $99M Series B
For the second day in a row, a European radiopharma company said it has bagged a large venture funding round.
Basel and Munich-based startup Nuclidium …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.